PAG1 抗体 (AA 138-357)
-
- 抗原 See all PAG1 抗体
- PAG1 (phosphoprotein Associated with Glycosphingolipid Microdomains 1 (PAG1))
-
抗原表位
- AA 138-357
-
适用
- 大鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This PAG1 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC)
- 特异性
- The antibody is a rabbit polyclonal antibody raised against PAG1. It has been selected for its ability to recognize PAG1 in immunohistochemical staining and western blotting.
- 纯化方法
- Antigen-specific affinity chromatography
- 免疫原
- PAG1 (Ile138-Phe357)
- 亚型
- IgG
- Top Product
- Discover our top product PAG1 Primary Antibody
-
-
- 应用备注
-
- Western blotting: 1:50-400 Immunocytochemistry in formalin fixed cells: 1:50-500 Immunohistochemistry in formalin fixed frozen section: 1:50-500 Immunohistochemistry in paraffin section: 1:10-100 Enzyme-linked Immunosorbent Assay: 1:100-1:5000 Optimal working dilutions must be determined by end user.
- 说明
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- Lot specific
- 缓冲液
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
-
- 抗原
- PAG1 (phosphoprotein Associated with Glycosphingolipid Microdomains 1 (PAG1))
- Abstract
- PAG1 产品
- 别名
- Cbp antibody, F730007C19Rik antibody, Pag antibody, CBP antibody, PAG antibody, MGC80192 antibody, phosphoprotein associated with glycosphingolipid microdomains 1 antibody, phosphoprotein membrane anchor with glycosphingolipid microdomains 1 antibody, phosphoprotein membrane anchor with glycosphingolipid microdomains 1 L homeolog antibody, Pag1 antibody, PAG1 antibody, pag1.L antibody, pag1 antibody
- 背景
- Alternative Names: CBP, PAG, Csk-Binding Protein, Transmembrane adapter protein PAG, Transmembrane phosphoprotein Cbp
- 途径
- p53 Pathway, TCR Signaling, EGFR Signaling Pathway, CXCR4-mediated Signaling Events
-